Aims of the study: Regulation of the penile smooth muscle tone and contractility is closely related to the activity of vasoactive substances, angiotensin II or nitric oxide. We investigated the relationship between gene polymorphism in the angiotensin converting enzyme (ACE) or endothelial nitric oxide synthase (ecNOS) and development of erectile dysfunction. Methods: In 84 subjects with organic erectile dysfunction and 63 control subjects, gene polymorphisms in the ACE and ecNOS were determined by the polymerase chain reaction (PCR). Results: The DD genotype of ACE was signi®cantly (P`0.01) more frequent in subjects with organic erectile dysfunction (54%) than in control subjects (24%). There was no signi®cant difference in the distribution of the genotypes of ecNOS. Conclusion: The deletion polymorphism in the ACE gene, the DD genotype, as a marker of general vascular disease, may be seen more frequently in men with a diagnosis of vasculogenic erectile dysfunction.
Introduction
The regulation of corporal smooth muscle tone is important in the process of penile erection. 1 Recently evidences are accumulating to suggest that angiotensin (ANG) II and nitric oxide (NO) may modulate cavernosal smooth muscle tone and contractility. 2 ± 4 Heritable factors, in combination with a number of recognized environmental risk factors, may be important determinants of the pathogenesis of erectile dysfunction. The renin-angiotensin system (RAS) plays a central role in the maintenance of vascular and cavernosal smooth muscule tone. 2, 5 RAS has cross-talk with NO-cyclic GMP pathway for erection in the cavernosal smooth muscle. 6 The angiotensin converting enzyme (ACE) gene (encoding kininase II) contains a polymorphism based on the presence (insertion [I] ) or absence (deletion [D] within an intron of a 287-base-pair ( bp) nonsense DNA domain, resulting in three genotypes (DD and II homozygotes, and ID heterozygotes). An insertiona deletion (IaD) polymorphism for the gene that encodes the ACE is associated with variation of circulating level of ACE. 7 The ACE DD genotype is associated with highest circulating and cellular concentration of ACE. 7 Associations have been found between the DD genotype and various conditions, including idiopathic dilated cardiomyopathy, 8 myocardial infarction, 9 and renal diseases. 10, 11 The local RAS inhibits penile erection by contracting penile smooth muscle. 2,3 ACE may be involved in the pathogenesis of erectile dysfunction because the activation of angiotensin (ANG) I to ANG II results in contraction of the penile smooth muscle. 2, 3 In addition, the inactivation of bradykinin potentially results in decreased tissue perfusion. 12 Furthermore, ACE inhibitors decrease contractions produced by ANG I in the corpus cavernosal smooth muscle.
A second gene that might be of importance for vascular diseases is the gene for endothelial nitric oxide synthase (ecNOS), an enzyme which is constitutively expressed in endothelial cells to produce NO. 13 Recently a polymorphism of the ecNOS gene was described and Wang et al 14 showed that the risk to develop coronary vascular disease in smokers was associated with a 27-base pair long repeat in the fourth intron of the gene (ecNOS a-allel). 14 NO is of pivotal importance for the physiologic vasodilatation, inhibits smooth muscle cell proliferation and prevents endothelial platelet adhesion. 15, 16 The structure and physiologic regulation of corpus cavernosal smooth muscle is similar to vascular smooth muscle. 17 As ACE regulates the RAS in vascular smooth muscle, it may do so in another target of renin-angiotensin, the corpus cavernosum. Therefore, DD genotype may be a risk factor for development of vasculogenic erectile dysfunction. Therefore, we have investigated a possible association between gene polymorphisms in ACE or ecNOS and the erectile dysfunction.
Methods
Eighty-four males with erectile dysfunction and sixty-three males without erectile dysfunction (controls) were recruited for this study. Patients with organic erectile dysfunction were evaluated with intra-cavernosal injection color doppler ultrasonography, routine and endocrine blood test. Males with erectile dysfunction due to psychogenic origin were excluded using Rigi-Scan 1 . The ages of men in the organic erectile dysfunctional group were 27 ± 70y old (mean 51 AE 4y, and in the control group were 30 ± 65y old (mean 48 AE 3). To evaluate the primary organic erectile dysfunction with no clinical vascular diseases, the patients with diseases such as diabetes mellitus, hypertension, and myocaridal infarction were excluded. The patients denied taking any medications that may impair sexual function. Thirty two percent of the patients and 28% of the control subjects were smokers.
Gene-polymorphisms in ACE and ecNOS were determined by the polymerase chain reaction (PCR). Genomic DNA was puri®ed from leukocytes in peripheral blood using a blood DNA kit (QIAGEN Inc., Chatsworth, CA, USA). To determine the ACE genotype of the patients and control subjects, a genomic DNA fragment on intron 16 of the ACE gene was ampli®ed by PCR techniques. The PCR yielded a 490 bp DNA fragment for insertion (I) allele from a human genomic DNA template and a 190 bp DNA fragment for the deletion (D) allele. The PCR that yielded both 490 bp and 190 bp DNA fragments were heterozygous for the IaD polymorphism. To avoid genotype mistyping, all samples yielding ampli®ca-tion of the D allele exclusively (and therefore potentially typed as DD) were subject to a second independent ampli®cation, insert speci®c PCR as described by Lindpaintner et al. 18 The ecNOS polymorphism was determined according to Wang et al. 14 The work has been approved by the Ethics Committee of the Chonbuk National University Medical School and consent was obtained from all participants following careful explanation of the aims and processes involved.
Statistics
Frequencies of the genotypes between the two groups of subjects were assessed by w 2 test.
Results
In the control group, the frequencies of the D and I alleles were 44 and 56%, and the frequencies of the DD, ID, and II genotypes observed were 24, 40, 36%, respectively. These data were similar to the published data for the Korean general population. 10, 19, 20 There were signi®cant differences in the distribution of the genotypes in erectile dysfunctional subjects compared with control subjects (Table 1) . The DD genotype was more frequent (P 0.0007) in the erectile dysfunctional subjects (54%) compared with controls (24%). Nineteen percent of erectile dysfunctional patients had the ID genotype which was lower than the 40% of control subjects with this genotype. Twenty-seven percent of erectile dysfunctional patients had the II genotype which was lower than the 36% of the control subjects with this genotype. Frequencies of the ecNOS bab, baa and aaa genotypes in the control group were 78%, 21% and 1%, respectively, and therefore comparable to data of the literature. 14 In patients with erectile dysfunction, the frequencies of the ecNOS bab, baa and aaa genotypes were 74%, 25% and 1% respectively. However, the frequency of distribution of the bab, baa and aaa genotypes did not differ between healthy controls and patients with erectile dysfunction (Table 2) . 3 These results suggest that RAS functions as a local regulator for the control of the corpus cavernosal smooth muscle. Several biologic actions of ACE could be involved in the pathogenesis of sexual dysfunction: ACE converts ANG I to ANG II and inactivates circulating bradykinin, which relaxes the human corpus cavernosum by releasing endothelium dependent relaxing factor (nitric oxide). 12, 21 Angiotensin-mediated promotion of cell growth may be involvd in the pathogenesis of vasculature remodeling in artherosclerosis. 9, 22, 23 Many characteristics of the corpus cavernosal smooth muscle are similar to those of the vascular smooth muscle. 17 RAS has an imoportant role in regulation of vascular smooth muscle tone 24 and erectile dysfunciton is caused by the disturbance of penile vascular hemodynamics. Erectile dysfunction occurred by vascular lesions is related to vascular diseases, such as myocardial infarction, hypertension, and atherosclerosis. 25 ± 28 The associations between the IaD polymorphism of the ACE gene and cardiovascular diseases including myocardial infarction and atherosclerosis 8, 27 suggest that alteration of the ACE gene may be involved in the pathophysiology of erectile dysfunction. Our results that the DD genotype was more frequent in the erectile dysfunctional subjects compared with controls were consistent with this suggestion. The mechanism underlying the association of the DD genotype with the erectile dysfunction is of much interest. ACE plays a key role in the RAS and kallikrein-kinin system by activating ANG I into ANG II and by activating bradykinin. 12 We speculate that the local availability of ANG II and bradykinin plays an important role in the determination of sexual dysfunction. 28 An IaD polymorphism of the ACE gene has been shown to be a genetic factor in¯uencing the ACE level in circulation and tissue: ACE activity is higher in the order of DD b ID b II. 7 Therefore we could expect that DD genotype may serve as a marker for increased risk for vascular disease including vasculogenic erectile dysfunction.
The frequencies of I and D allele in our controls were different from those of Caucasian populations, but very similar to those of Korean 8, 18, 19 and Japanese population. 21, 29 Although these differences may be due to selection bias of normal control subjects, it is most likely to be due to ethnic differences.
In the second part of this present study we analyzed the relationship between a recently described polymorphism in the ecNOS gene and the erectile dysfunction. In cavernosal tissues, a balance between ANG II and NO modulates smooth muscle tone, thereby regulating regional blood¯ow. 6 These vasoactive substances mediate opposing actions, with NO causing a decrease and Ang II mediating an increase in smooth muscle tone. Unlike in the case of the ACE gene polymorphism, we failed to detect any signi®cant associations between the ecNOS genotype and erectile dysfunction.
Although the mechanism by which ACE IaD polymorphism increases the risk of developing erectile dysfunction is unclear, it has been suggested that the DD genotype, which is signi®cantly more frequent in patients with erectile dysfunction than in controls seems to be a risk factor of the vascular diseases including the vasculogenic erectile dysfunction. Further studies are needed to clarify if patients with erectile dysfunction and the DD genotype can be treated by ACE inhibition or other pharmacologic interventions.
Conclusions
It is the ®rst report to suggest that erectile dysfunction may be related with ACE gene-polymorphism. Our report suggests that the deletion polymorphism in the ACE gene, the DD genotype, marker of increased risk for development of vascular disease, may be seen more frequently in men with a diagnosis of vasculogenic erectile dysfunction.
